for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Nissan Chemical Corp

4021.T

Latest Trade

4,555.00JPY

Change

-5.00(-0.11%)

Volume

592,600

Today's Range

4,520.00

 - 

4,590.00

52 Week Range

4,285.00

 - 

6,370.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4,560.00
Open
4,565.00
Volume
592,600
3M AVG Volume
11.56
Today's High
4,590.00
Today's Low
4,520.00
52 Week High
6,370.00
52 Week Low
4,285.00
Shares Out (MIL)
145.97
Market Cap (MIL)
668,850.00
Forward P/E
21.97
Dividend (Yield %)
1.80

Next Event

Dividend For 4021.T - 42.0000 JPY

Latest Developments

More

Nissan Chemical To Buy Back Up To 1.15% Of Shares Worth 6 Billion Yen Through Aug 30

Nissan Chemical Corp Says To Buy Back Up To 0.61 Percent Of Own Shares Worth 4 Billion Yen Through April 26

Nissan Chemical Industries to change company name to Nissan Chemical Corporation

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Nissan Chemical Corp

Nissan Chemical Corporation, formerly Nissan Chemical Industries, Ltd., is a Japan-based chemical manufacturing company. The Company operates in six business segments. The Chemicals segment offers basic chemicals, including melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. The Functional Materials segment offers display materials, semiconductor materials and inorganic colloid. The Agricultural Chemicals segment offers herbicides, insecticides, fungicides, plant growth agent and other agrichemicals. The Medicinal Drug segment offers drug for the treatment of hypercholesterolemia. The Wholesales segment involves in the wholesale of chemical products. The Others segment provides fertilizers, as well as involves in green landscaping, transportation and plant engineering businesses.

Industry

Chemical Manufacturing

Contact Info

2-5-1, Nihombashi

+81.3.44638111

https://www.nissanchem.co.jp/

Executive Leadership

Kojiro Kinoshita

President, Representative Director

Hironori Yoshida

Executive Officer, Director of Finance

Hiroyoshi Fukuro

Vice President, Director

Junichi Miyazaki

Vice President, Director

Hidenori Takishita

Managing Executive Officer, Director of Human Resources

Key Stats

2.36 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.2K

2018

0.2K

2019

0.2K

2020(E)

0.2K
EPS (JPY)

2017

156.970

2018

180.300

2019

197.670

2020(E)

207.065
Price To Earnings (TTM)
23.75
Price To Sales (TTM)
3.30
Price To Book (MRQ)
3.79
Price To Cash Flow (TTM)
17.05
Total Debt To Equity (MRQ)
5.13
LT Debt To Equity (MRQ)
0.63
Return on Investment (TTM)
15.85
Return on Equity (TTM)
12.93

Latest News

BRIEF-Cadila Healthcare says Zydus announces settlement for Livalo tablets

* Cadila Healthcare Ltd says Zydus announces settlement with Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd. on livalo (pitavastatin calcium) tablets

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up